AUSTIN, Texas, Dec. 19, 2024 /PRNewswire/ -- Alafair Biosciences announced today that it has surpassed 22,000 patient implants of its flagship product, VersaWrap Hydrogel Sheet, marking a significant ...

AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle ...

AUSTIN, Texas, Nov. 21, 2023 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that surgeons have implanted over 12,000 units of its flagship product, ...

AUSTIN, Texas, March 5, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, announced business results for 2024, marking a year of growth and expansion.

AUSTIN, Texas, Sept. 16, 2024 /PRNewswire/ -- Alafair Biosciences is proud to announce that it has been selected to exhibit its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), at the Vizient ...

Alafair Biosciences, Inc., a privately held medical device company, announced that its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), has been awarded a national group purchasing agreement ...

AUSTIN, Texas, Oct. 4, 2022 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that sales of its flagship product, VersaWrap®, have now exceeded 5000 units ...

VersaWrap is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA) and alginate that provides a gelatinous encasement for peripheral nerves, tendons, and surrounding ...

"It's tremendously gratifying to know that our technology is helping so many patients," said John Joyoprayitno, co-founder, President, and CEO of Alafair Biosciences. "This achievement would not be ...